Effect of cyproheptadine and atropine on the diurnal prolactin responses to insulin-induced hypoglycemia in normal men.

There is a diurnal variation in the PRL response to insulin-induced hypoglycemia in normal men, with a substantially larger response in the evening. This study investigated the possible serotonergic and cholinergic influences on these diurnal PRL responses. Morning and evening PRL responses to hypoglycemia were compared in the same five normal young men without drug pretreatment, after cyprohepatadine, and after atropine sulfate. Cyproheptadine had no effect on the basal PRL concentration or the PRL response to hypoglycemia in either the morning or evening. Atropine had no effect on basal PRL concentrations in the morning or evening or on the morning PRL response to hypoglycemia. However, the evening PRL response was significantly inhibited by atropine (P less than 0.02), with an abolition of the normal diurnal difference in response (P less than 0.001) to insulin-induced hypoglycemia. These data suggest the involvement of a cholinergic mechanism in regulation of diurnal PRL responses to hypoglycemia.

[1]  G. Delitala,et al.  Enhancement of insulin-induced prolactin secretion by fluoxetine in man. , 1979, The Journal of clinical endocrinology and metabolism.

[2]  G. Langer,et al.  Diurnal variation in the response of plasma prolactin, cortisol, and growth hormone to insulin-induced hypoglycemia in normal men. , 1979, The Journal of clinical endocrinology and metabolism.

[3]  A. E. Boyd,et al.  Neural control of prolactin secretion in man , 1978, Psychoneuroendocrinology.

[4]  P. Woolf,et al.  Dopamine affects basal and augmented pituitary hormone secretion. , 1978, The Journal of clinical endocrinology and metabolism.

[5]  W. Mendelson,et al.  Methoscopolamine inhibition of sleep-related growth hormone secretion. Evidence for a cholinergic secretory mechanism. , 1978, The Journal of clinical investigation.

[6]  S. Handwerger,et al.  Failure of L-tryptophan to stimulate prolactin secretion in man. , 1977, The Journal of clinical endocrinology and metabolism.

[7]  I. Lancranjan,et al.  Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man. , 1977, The Journal of clinical endocrinology and metabolism.

[8]  M. Subramanian,et al.  Influence of cholinergic receptor blockade on drug-induced prolactin release in the monkey. , 1976, Hormone Research.

[9]  K. Chihara,et al.  Effect of 5-hydroxytryptophan (5-HTP) on plasma prolactin levels in man. , 1974, The Journal of clinical endocrinology and metabolism.

[10]  J. Meites,et al.  Inhibition of Prolactin Secretion by Cholinergic Drugs , 1974 .

[11]  U. Lewis,et al.  A homologous radioimmunoassay for human prolactin. , 1973, The Journal of clinical endocrinology and metabolism.

[12]  E. Sachar,et al.  The use of the prolactin response in clinical psychopharmacology [proceedings]. , 1977, Psychopharmacology bulletin.

[13]  M. Subramanian,et al.  Further studies on the effects of adrenergic, serotonergic and cholinergic drugs on the afternoon surge of plasma prolactin in ovariectomized, estrogen-treated rats. , 1976, Neuroendocrinology.

[14]  P. Beck‐Peccoz,et al.  Failure of oral 5-hydroxytryptohan administration to affect prolactin secretion in man. , 1976, Hormone research.

[15]  C. A. Stone,et al.  ANTISEROTONIN-ANTIHISTAMINIC PROPERTIES OF CYPROHEPTADINE , 1961 .